ATE160376T1 - Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert - Google Patents

Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert

Info

Publication number
ATE160376T1
ATE160376T1 AT91915865T AT91915865T ATE160376T1 AT E160376 T1 ATE160376 T1 AT E160376T1 AT 91915865 T AT91915865 T AT 91915865T AT 91915865 T AT91915865 T AT 91915865T AT E160376 T1 ATE160376 T1 AT E160376T1
Authority
AT
Austria
Prior art keywords
marek
glycoprotein
codes
dna segment
herpes virus
Prior art date
Application number
AT91915865T
Other languages
English (en)
Inventor
Leland F Velicer
Peter Brunovskis
Paul M Coussens
Original Assignee
Univ Michigan State
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=27075921&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ATE160376(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Priority claimed from US07/572,711 external-priority patent/US5138033A/en
Application filed by Univ Michigan State filed Critical Univ Michigan State
Application granted granted Critical
Publication of ATE160376T1 publication Critical patent/ATE160376T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16311—Mardivirus, e.g. Gallid herpesvirus 2, Marek-like viruses, turkey HV
    • C12N2710/16322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Virology (AREA)
  • Biochemistry (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
AT91915865T 1990-08-24 1991-08-19 Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert ATE160376T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US07/572,711 US5138033A (en) 1990-08-24 1990-08-24 Marek's disease herpesvirus glycoproteins GE
US07/736,335 US6087127A (en) 1990-08-24 1991-07-25 Marek's disease herpesvirus DNA segment encoding glycoproteins, gD, gI and gE

Publications (1)

Publication Number Publication Date
ATE160376T1 true ATE160376T1 (de) 1997-12-15

Family

ID=27075921

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91915865T ATE160376T1 (de) 1990-08-24 1991-08-19 Dna segment des herpesvirus der marek-krankheit, welches für das glykoprotein ge kodiert

Country Status (11)

Country Link
US (2) US6087127A (de)
EP (1) EP0502146B1 (de)
JP (1) JP2527872B2 (de)
AT (1) ATE160376T1 (de)
AU (1) AU636247B2 (de)
CA (1) CA2066160A1 (de)
DE (1) DE69128239T2 (de)
DK (1) DK0502146T3 (de)
ES (1) ES2110999T3 (de)
GR (1) GR3025821T3 (de)
WO (1) WO1992003547A1 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69101683T2 (de) * 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
AU657144B2 (en) * 1991-07-09 1995-03-02 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Recombinant Marek's disease virus, process for preparing the same and vaccine containing the same
US6913751B2 (en) * 1992-06-12 2005-07-05 Schering-Plough Veterinary Corporation Recombinant avian herpesvirus useful in vaccine production
US6984728B2 (en) 1993-09-24 2006-01-10 Schering Corporation Recombinant infectious laryngotracheitis virus and uses thereof
FR2719056B1 (fr) * 1994-04-20 1996-09-06 Rhone Merieux Herpesvirus transformés pour exprimer gD in vitro.
JP3964458B2 (ja) * 1995-03-23 2007-08-22 シェリング−プロウ・リミテッド 組換え型伝染性喉頭気管炎ウイルスおよびその使用
US7314715B2 (en) 2001-06-14 2008-01-01 Schering-Plough Animal Health Corporation Recombinant avian herpesvirus useful in vaccine production
GB0313132D0 (en) * 2003-06-06 2003-07-09 Ich Productions Ltd Peptide ligands
CN116042709B (zh) * 2022-09-23 2025-01-14 广西大学 一种共表达马立克病病毒糖蛋白gC和gD的DNA疫苗构建方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0434747B1 (de) * 1988-09-13 1999-05-19 Merial AUF DEM gB-PROTEIN DES MAREK'S DISEASE VIRUS (MDV) BASIERENDE, REKOMBINANTE IMPFSTOFFE
DE69101683T2 (de) * 1990-07-30 1994-07-21 Akzo Nv Rekombinantes Mareks-Krankheitsvirus.
FR2666589B1 (fr) * 1990-09-07 1994-08-05 Rhone Merieux Nouveaux virus herpes recombinants, vaccin a base de ces recombinants, leur procede de preparation, genes, vecteurs et plasmides utilises dans ce procede.
PT623172E (pt) * 1992-01-13 2005-02-28 Virogenetics Corp Vacina de virus vaccinia recombinante do virus da doenca de marek

Also Published As

Publication number Publication date
CA2066160A1 (en) 1992-02-25
EP0502146A1 (de) 1992-09-09
US5976787A (en) 1999-11-02
JPH04505106A (ja) 1992-09-10
DE69128239D1 (de) 1998-01-02
US6087127A (en) 2000-07-11
WO1992003547A1 (en) 1992-03-05
AU8496591A (en) 1992-03-17
DK0502146T3 (da) 1998-07-27
EP0502146B1 (de) 1997-11-19
JP2527872B2 (ja) 1996-08-28
ES2110999T3 (es) 1998-03-01
EP0502146A4 (de) 1994-08-03
GR3025821T3 (en) 1998-03-31
AU636247B2 (en) 1993-04-22
DE69128239T2 (de) 1998-03-12

Similar Documents

Publication Publication Date Title
ATE258188T1 (de) Retro-, inverso-, und retro-inverso synthetische peptidanaloge
DE69635907D1 (de) Neuartige nicht pyrogene bakterienstämme und ihre verwendung
ATE267258T1 (de) Impfstoffe für das respiratorische-synzytial- virus mit nuklein säuren
HU9401056D0 (en) Porcine reproductive respiratory syndrome vaccine and diagnostic
ES2009350A6 (es) Procedimiento para la preparacion de vectores de expresion que codifican una nueva proteina.
ES2193133T3 (es) Uso de peptidos derivados de los genes e6 y e7 de hpv-16 para fines.
NO874750L (no) Bestemte dna-sekvenser avledet fra et papillomavirusgenom, deres bruk i in vitro diagnostikk og produksjon av antigene preparater.
DE3677494D1 (de) Virus-impfstoff.
NO20000850D0 (no) Vaksine
KR900700508A (ko) 인간의 호흡기 합포체성 바이러스에 대한 당단백질 면역 단편을 함유하는 키메라(chimeric) 당단백질
ES8203226A1 (es) Procedimiento de preparar complejos vacunantes por reaccion de arn ribonosales y de antigenos especificos.
HUP9901112A2 (hu) Szintetikus HIV-gének
DK1108035T3 (da) Behandling af cervixcancer
ATE105334T1 (de) Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
DE69128239D1 (de) DNA SEGMENT DES HERPESVIRUS DER MAREK-KRANKHEIT, WELCHES FÜR DAS GLYKOPROTEIN gE KODIERT
HUP9801334A2 (hu) A 18-as típusú humán papillomavírust kódoló DNS
ES8504254A1 (es) Procedimiento para obtener un polipeptido
HUP9901005A2 (hu) Herpeszvírusok RFHV/KSHV-alcsaládjába tartozó vírusokból származó glikoprotein-B
EP0294469A4 (de) Impfstoffe und diagnosetest für haemophilus influenzae.
PT586076E (pt) Vacinas de adenovirus recombinantes
ATE223492T1 (de) Mutanten des infektiösen rinder rhinotracheitis- virus und impfstoffe
ATE102650T1 (de) Mutanten des infektioesen bovinen rhinotracheitisvirus, vakzine die sie enthalten, verfahren zu ihrer herstellung und ihrer verwendung.
MX9605139A (es) Linea celular de pollo, sostenible, infectada con el virus de la enfermedad de marek.
DE69131984D1 (de) Das für das pferde herpes-virus typ 1 glykoprotein d, kodierende gen, sein genprodukt, antikörper und ihre verwendung
MX9602256A (es) Vacuna contra la enfermedad de marek.